苯巴那酯价格一览

Phenobarnate is an innovative drug used to treat partial-onset epilepsy in adults. There is a significant price difference between its original drug and generic drugs. At the same time, the drug’s domestic launch process and medical insurance reimbursement status have also attracted much attention. This article will introduce in detail the price difference between the original drug and generic drugs of Phenobarate, the domestic marketing situation and the medical insurance reimbursement situation.

Phenobanalate original drug and generic drug prices

Original drug price

The original drug was developed by the Italian ANGELINI company, and its price is relatively high.

Different specifications of Phenobarnate have different prices. A box of 12.5+25mg*28 tablets costs about US$207, a box of 50mg*84 tablets costs about US$524, and a box of 200mg* The price of a box of 84 tablets is about US$524, the price of a box of 50mg*28 tablets is about US$232, the price of a box of 50mg*14 tablets is about US$117, and the price of 50mg and 100mg is the same.

Price of generic drugs

Currently, we are not aware of any generic version of Phenobarnate, so we cannot know the specific price of generic drugs at the moment.

The marketing situation of Phenomenate in China

As of now, Phenomenate has not been marketed in China, and patients in China cannot purchase the drug directly through regular pharmacies or hospital channels. Although Phenobarate is not marketed in China, patients can still obtain it through cross-border e-commerce platforms or international medical service institutions and other channels.

Factors affecting the marketing process

The domestic marketing process of Phenobarate is affected by a variety of factors. The progress of clinical trials is one of the key factors that determine whether the drug can be marketed. Phenobarate needs to pass a series of rigorous clinical trials to verify its efficacy and safety. These trials require a lot of time and resources.

Adjustments in regulatory policies may also have an impact on the drug launch process. For example, adjustments to drug approval policies and increased regulatory requirements may lead to delays in the launch of drugs.

Suggestions on how to obtain it for patients

For patients who are in urgent need of phebanate, they can obtain it through cross-border e-commerce platforms or international medical service institutions. However, it should be noted that these channels may have problems such as price differences and uneven drug quality. Therefore, patients need to carefully choose reputable merchants and carefully check the authenticity of drugs.

Phenobarnate’s medical insurance reimbursement situation

Because phenobarnate has not yet been launched in China, it is not yet included in the scope of medical insurance reimbursement. Patients need to bear all costs when using phenobarnate. With the continuous advancement of medical technology and the continuous improvement of medical insurance policies, phenobarate is expected to be included in the scope of medical insurance reimbursement in the future to reduce the financial burden of patients.

Changes in medical insurance reimbursement policies

Medical insurance reimbursement policies are a dynamically changing process. With the continuous advancement of medical technology and the continuous enrichment of medical insurance funds, more and more innovative drugs are expected to be included in the scope of medical insurance reimbursement.

With the continuous advancement of the domestic launch of Phenobarate and the continuous accumulation of clinical trial data, it is expected to be included in the scope of medical insurance reimbursement in the future to reduce the financial burden of patients. At the same time, patients can also pay attention to changes in relevant policies and regulations, and keep abreast of the medical insurance reimbursement status of phenobarate.

Patient Financial Assistance Paths

While waiting for Phenobarate to be included in the scope of medical insurance reimbursement, patients can seek financial assistance and support through other channels. They can apply for relief funds or drug donations from relevant charities or social organizations, or they can participate in clinical trials to obtain free or discounted treatment opportunities.